73
|
220
|
5qc7A |
Crystal structure of human cathepsin-s with bound ligand |
67
|
219
|
5qbuA |
Crystal structure of human cathepsin-s with bound ligand |
71
|
219
|
5qbxA |
Crystal structure of human cathepsin-s with bound ligand |
71
|
219
|
5qcaA |
Crystal structure of human cathepsin-s with bound ligand |
72
|
220
|
5qc0A |
Crystal structure of human cathepsin-s with bound ligand |
72
|
221
|
5qc3A |
Crystal structure of human cathepsin-s with bound ligand |
68
|
217
|
5qbzA |
Crystal structure of human cathepsin-s with bound ligand |
74
|
221
|
5qc9A |
Crystal structure of human cathepsin-s with bound ligand |
73
|
220
|
5qbvA |
Crystal structure of human cathepsin-s with bound ligand |
73
|
219
|
5qbyA |
Crystal structure of human cathepsin-s with bound ligand |
54
|
212
|
5padA |
Binding of chloromethyl ketone substrate analogues to crystalline papain |
73
|
220
|
5maeA |
Cathepsin l in complex with (2s,4r)-4-(2-chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2-yl)-azetidine-3-carbonyl]-pyrrolidine-2-car boxylic acid (1-cyano-cyclopropyl)-amide |
81
|
255
|
5mblA |
Cathepsin b in complex with darpin 81 |
67
|
223
|
5j94A |
Human cathepsin k mutant c25s in complex with the allosteric effector nsc13345 |
92
|
306
|
5fpwA |
Procathepsin b s9 from trypanosoma congolense |
72
|
220
|
5f02A |
Cathepsin l in complex with (2s,4r)-4-(2-chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2-yl)-azetidine-3-carbonyl]-pyrrolidine-2-carboxylic acid (1-cyano-cyclopropyl)-amide |
107
|
365
|
5egwA |
2.70 a crystal structure of the amb a 11 cysteine protease, a major ragweed pollen allergen, in its proform |
108
|
342
|
5ef4A |
2.05 a crystal structure of the amb a 11 cysteine protease, a major ragweed pollen allergen, in its proform |
62
|
215
|
4xuiA |
Crystal structure analysis of cruzain bound to the no-covalent analog of wrr-483 (wrr-669) |
65
|
215
|
4x6iA |
Development of n-(functionalized benzoyl)-homocycloleucyl-glycinonitriles as potent cathepsin k inhibitors. |
72
|
215
|
4w5bA |
Crystal structure analysis of cruzain with fragment 1 (n-(1h-benzimidazol-2-yl)-1,3-dimethyl-pyrazole-4-carboxamide) |
67
|
215
|
4x6hA |
Development of n-(functionalized benzoyl)-homocycloleucyl-glycinonitriles as potent cathepsin k inhibitors. |
65
|
215
|
4x6jA |
Development of n-(functionalized benzoyl)-homocycloleucyl-glycinonitriles as potent cathepsin k inhibitors. |
67
|
215
|
4w5cA |
Crystal structure analysis of cruzain with three fragments: 1 (n-(1h-benzimidazol-2-yl)-1,3-dimethyl-pyrazole-4-carboxamide), 6 (2-amino-4,6-difluorobenzothiazole) and 9 (n-(1h-benzimidazol-2-yl)-3-(4-fluorophenyl)-1h-pyrazole-4-carboxamide). |
109
|
316
|
4qrvA |
Crystal structure of i86f mutant of papain |
95
|
304
|
4qrxA |
Crystal structure of pro-papain mutant at ph 4.0 |
110
|
316
|
4qrgA |
Crystal structure of i86l mutant of papain |
67
|
215
|
4qh6A |
Crystal structure of cruzain with nitrile inhibitor n-(2-aminoethyl)-nalpha-benzoyl-l-phenylalaninamide |
69
|
215
|
4pi3A |
Crystal structure analysis of cruzain bound to vinyl sulfone analog of wrr-483 (wrr-666) |
70
|
219
|
4p6gA |
Crystal structure of human cathepsin s bound to a non-covalent inhibitor. |
54
|
212
|
4padA |
Binding of chloromethyl ketone substrate analogues to crystalline papain |
57
|
222
|
4pp1A |
The crystal structure of der p 1 allergen complexed with fab fragment of mab 5h8 |
69
|
219
|
4p6eA |
Crystal structure of human cathepsin s bound to a non-covalent inhibitor |
63
|
222
|
4pp2E |
The crystal structure of der p 1 allergen complexed with fab fragment of mab 10b9 |
82
|
314
|
4n4zA |
Trypanosoma brucei procathepsin b structure solved by serial microcrystallography using synchrotron radiation |
59
|
215
|
4n79A |
Structure of cathepsin k-dermatan sulfate complex |
66
|
213
|
4n8wA |
Cathepsin k - chondroitin sulfate complex |
67
|
218
|
4mzoA |
Mouse cathepsin s with covalent ligand (3s,4s)-n-[(2e)-2-iminoethyl]-4-(morpholin-4-ylcarbonyl)-1-(phenylsulfonyl)pyrrolidine-3-carboxamide |
66
|
218
|
4mzsA |
Mouse cathepsin s with covalent ligand (3s,4s)-1-[(2-chlorophenyl)sulfonyl]-n-[(2e)-2-iminoethyl]-4-(morpholin-4-ylcarbonyl)pyrrolidine-3-carboxamide |
69
|
215
|
4klbA |
Crystal structure of cruzain in complex with the non-covalent inhibitor nequimed176 |
98
|
314
|
4hwyA |
Trypanosoma brucei procathepsin b solved from 40 fs free-electron laser pulse data by serial femtosecond x-ray crystallography |
105
|
315
|
4i04A |
Structure of zymogen of cathepsin b1 from schistosoma mansoni |
81
|
253
|
4i07A |
Structure of mature form of cathepsin b1 from schistosoma mansoni |
95
|
277
|
4i05A |
Structure of intermediate processing form of cathepsin b1 from schistosoma mansoni |
87
|
253
|
3qsdA |
Structure of cathepsin b1 from schistosoma mansoni in complex with ca074 inhibitor |
113
|
310
|
3qt4A |
Structure of digestive procathepsin l 3 of tenebrio molitor larval midgut |
105
|
319
|
3qj3A |
Structure of digestive procathepsin l2 proteinase from tenebrio molitor larval midgut |
98
|
441
|
3pdfA |
Discovery of novel cyanamide-based inhibitors of cathepsin c |
65
|
240
|
3pnrA |
Structure of pbicp-c in complex with falcipain-2 |
67
|
317
|
3pbhA |
Refined crystal structure of human procathepsin b at 2.5 angstrom resolution |